
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 744-757
Closed Access | Times Cited: 105
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 744-757
Closed Access | Times Cited: 105
Showing 1-25 of 105 citing articles:
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
Robert A. McCutcheon, Richard S.E. Keefe, Philip McGuire
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 1902-1918
Open Access | Times Cited: 305
Robert A. McCutcheon, Richard S.E. Keefe, Philip McGuire
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 1902-1918
Open Access | Times Cited: 305
Candidate biomarkers in psychiatric disorders: state of the field
Anissa Abi‐Dargham, Scott J. Moeller, Farzana Ali, et al.
World Psychiatry (2023) Vol. 22, Iss. 2, pp. 236-262
Open Access | Times Cited: 155
Anissa Abi‐Dargham, Scott J. Moeller, Farzana Ali, et al.
World Psychiatry (2023) Vol. 22, Iss. 2, pp. 236-262
Open Access | Times Cited: 155
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment
Masataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 7, pp. 2950-2967
Closed Access | Times Cited: 72
Masataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 7, pp. 2950-2967
Closed Access | Times Cited: 72
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 57
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 57
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 46
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 46
Neurotransmitter function
Mitul A. Mehta, Peter C.T. Hawkins
Elsevier eBooks (2024), pp. 136-151
Closed Access | Times Cited: 42
Mitul A. Mehta, Peter C.T. Hawkins
Elsevier eBooks (2024), pp. 136-151
Closed Access | Times Cited: 42
Glutamatergic dysfunction in Schizophrenia
Andreas O. Kruse, Juan Bustillo
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 64
Andreas O. Kruse, Juan Bustillo
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 64
Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
Thomas McGrath, Richard Baskerville, Marcelo Macedo Rogero, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 917-917
Open Access | Times Cited: 53
Thomas McGrath, Richard Baskerville, Marcelo Macedo Rogero, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 917-917
Open Access | Times Cited: 53
Functional MRS studies of GABA and glutamate/Glx – A systematic review and meta-analysis
Duanghathai Pasanta, Jason He, Talitha C. Ford, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104940-104940
Open Access | Times Cited: 43
Duanghathai Pasanta, Jason He, Talitha C. Ford, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104940-104940
Open Access | Times Cited: 43
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis
Kate Merritt, Robert A. McCutcheon, André Alemán, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 2039-2048
Open Access | Times Cited: 37
Kate Merritt, Robert A. McCutcheon, André Alemán, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 2039-2048
Open Access | Times Cited: 37
MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
Heng-Chang Zhang, Yang Du, Lei Chen, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105064-105064
Closed Access | Times Cited: 32
Heng-Chang Zhang, Yang Du, Lei Chen, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105064-105064
Closed Access | Times Cited: 32
Psychotic disorders as a framework for precision psychiatry
Fiona Coutts, Nikolaos Koutsouleris, Philip McGuire
Nature Reviews Neurology (2023)
Closed Access | Times Cited: 23
Fiona Coutts, Nikolaos Koutsouleris, Philip McGuire
Nature Reviews Neurology (2023)
Closed Access | Times Cited: 23
Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment
Andrea de Bartolomeis, Giuseppe De Simone, Michele De Prisco, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2811-2825
Open Access | Times Cited: 23
Andrea de Bartolomeis, Giuseppe De Simone, Michele De Prisco, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2811-2825
Open Access | Times Cited: 23
New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction
Oliver Howes, Eleanor Dawkins, Maria Lobo, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 8, pp. 638-650
Open Access | Times Cited: 14
Oliver Howes, Eleanor Dawkins, Maria Lobo, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 8, pp. 638-650
Open Access | Times Cited: 14
The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
Daniela L. Uliana, João Roberto Lisboa, Felipe V. Gomes, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116298-116298
Closed Access | Times Cited: 13
Daniela L. Uliana, João Roberto Lisboa, Felipe V. Gomes, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116298-116298
Closed Access | Times Cited: 13
New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment
Pawan Faris, Doris Pischedda, Fulvia Palesi, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 8
Pawan Faris, Doris Pischedda, Fulvia Palesi, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 8
Exploring causal mechanisms of psychosis risk
Dominic Oliver, Edward Chesney, Alexis E. Cullen, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105699-105699
Open Access | Times Cited: 6
Dominic Oliver, Edward Chesney, Alexis E. Cullen, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105699-105699
Open Access | Times Cited: 6
Hippocampal circuit dysfunction in psychosis
Samuel Knight, Robert A. McCutcheon, Daniella Dwir, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Samuel Knight, Robert A. McCutcheon, Daniella Dwir, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Neurofunctional correlates of glutamate and GABA imbalance in psychosis: A systematic review
Uzma Zahid, Ellis Chika Onwordi, Emily Hedges, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 105010-105010
Open Access | Times Cited: 23
Uzma Zahid, Ellis Chika Onwordi, Emily Hedges, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 105010-105010
Open Access | Times Cited: 23
Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy study
Edgardo Torres‐Carmona, Ali Abdolizadeh, Yusuke Iwata, et al.
Schizophrenia Research (2024) Vol. 270, pp. 152-161
Closed Access | Times Cited: 4
Edgardo Torres‐Carmona, Ali Abdolizadeh, Yusuke Iwata, et al.
Schizophrenia Research (2024) Vol. 270, pp. 152-161
Closed Access | Times Cited: 4
Psychosis of Epilepsy: An Update on Clinical Classification and Mechanism
Zhu Qiu, Jiawen Guo, Bofei Chen, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 56-56
Open Access
Zhu Qiu, Jiawen Guo, Bofei Chen, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 56-56
Open Access
Changes in glutamate levels in anterior cingulate cortex following 16 weeks of antipsychotic treatment in antipsychotic-naïve first-episode psychosis patients
Jose O. Maximo, Eric Nelson, Nina V. Kraguljac, et al.
Psychological Medicine (2025) Vol. 55
Closed Access
Jose O. Maximo, Eric Nelson, Nina V. Kraguljac, et al.
Psychological Medicine (2025) Vol. 55
Closed Access
The Relationship Among Range Adaptation, Social Anhedonia, and Social Functioning: A Combined Magnetic Resonance Spectroscopy and Resting-State fMRI Study
Lin Wang, Gaiying Li, Chao Yan, et al.
Schizophrenia Bulletin (2025) Vol. 51, Iss. Supplement_2, pp. S160-S172
Open Access
Lin Wang, Gaiying Li, Chao Yan, et al.
Schizophrenia Bulletin (2025) Vol. 51, Iss. Supplement_2, pp. S160-S172
Open Access
An anti-Hebbian model for binocular visual plasticity and its attentional modulation
Zhengbo Chen, Yong‐Chun Cai
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Zhengbo Chen, Yong‐Chun Cai
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia
Kamiyu Ogyu, Karin Matsushita, Shiori Honda, et al.
Schizophrenia Research (2023) Vol. 252, pp. 129-137
Open Access | Times Cited: 12
Kamiyu Ogyu, Karin Matsushita, Shiori Honda, et al.
Schizophrenia Research (2023) Vol. 252, pp. 129-137
Open Access | Times Cited: 12